Literature DB >> 22361978

The spectrum of clinicopathological features in pure autonomic neuropathy.

Haruki Koike1, Rina Hashimoto, Minoru Tomita, Yuichi Kawagashira, Masahiro Iijima, Shigeru Koyano, Takayuki Momoo, Hiroyuki Yuasa, Shigehisa Mitake, Mana Higashihara, Kenichi Kaida, Daisuke Yamamoto, Shin Hisahara, Shun Shimohama, Yoshiharu Nakae, Ken Johkura, Steven Vernino, Gen Sobue.   

Abstract

We assessed the clinicopathological features of nine patients with pure autonomic neuropathy, that is, neuropathy without sensory or motor deficits. The duration from symptom onset to diagnosis ranged from 1 month to 13 years. Of eight patients in whom serum antiganglionic acetylcholine receptor antibody was determined, four were positive. All patients who tested positive for this antibody manifested widespread autonomic dysfunction, with the exception of one patient who only experienced orthostatic hypotension. However, patients who were negative for the antiganglionic acetylcholine receptor antibody presented with partial autonomic failure. One of these patients had diffuse parasympathetic failure and generalized hypohidrosis but no orthostatic hypotension, which is clinically compatible with postganglionic cholinergic dysautonomia. Electron microscopic examination revealed a variable degree of reduction in unmyelinated fibers. Compared with normal controls, the patients had a significantly increased density of collagen pockets (p < 0.05). Additionally, the percentage of Schwann cell subunits with axons (out of the total number of Schwann cell subunits associated with unmyelinated fibers) was significantly decreased (p < 0.01). The density of unmyelinated fibers tended to decrease with increasing time between the onset of autonomic symptoms and biopsy (p < 0.05). In conclusion, the clinical and pathological features of pure autonomic neuropathy vary in terms of progression, autonomic involvement, presence of the antiganglionic acetylcholine receptor antibody, and loss of unmyelinated fibers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22361978     DOI: 10.1007/s00415-012-6458-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  44 in total

1.  Expanding the concept of inflammatory neuropathies.

Authors:  Haruki Koike; Gen Sobue
Journal:  Brain       Date:  2010-09-20       Impact factor: 13.501

2.  Behaviour of peripheral nerve structures in chronic neuropathies, with special reference to the Schwann cell.

Authors:  J Ochoa; J D Vial
Journal:  J Anat       Date:  1967-11       Impact factor: 2.610

3.  Unmyelinated nerve fibers in sural nerve in pure autonomic failure.

Authors:  T Kanda; H Tomimitsu; T Yokota; N Ohkoshi; M Hayashi; H Mizusawa
Journal:  Ann Neurol       Date:  1998-02       Impact factor: 10.422

4.  Clinicopathological features of acute autonomic and sensory neuropathy.

Authors:  Haruki Koike; Naoki Atsuta; Hiroaki Adachi; Masahiro Iijima; Masahisa Katsuno; Takeshi Yasuda; Yasuyo Fukada; Kenichi Yasui; Kenji Nakashima; Masahiro Horiuchi; Kazutaka Shiomi; Kazuhito Fukui; Shutaro Takashima; Yukari Morita; Kazumasa Kuniyoshi; Yasuhiro Hasegawa; Yasuhisa Toribe; Mitsugu Kajiura; Saoko Takeshita; Eiichiro Mukai; Gen Sobue
Journal:  Brain       Date:  2010-08-23       Impact factor: 13.501

Review 5.  Paraneoplastic neuropathy: wide-ranging clinicopathological manifestations.

Authors:  Haruki Koike; Fumiaki Tanaka; Gen Sobue
Journal:  Curr Opin Neurol       Date:  2011-10       Impact factor: 5.710

6.  Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy.

Authors:  Haruki Koike; Masahiro Iijima; Makoto Sugiura; Keiko Mori; Naoki Hattori; Hiroki Ito; Masaaki Hirayama; Gen Sobue
Journal:  Ann Neurol       Date:  2003-07       Impact factor: 10.422

Review 7.  Invited Article: Autonomic ganglia: target and novel therapeutic tool.

Authors:  Steven Vernino; Paola Sandroni; Wolfgang Singer; Phillip A Low
Journal:  Neurology       Date:  2008-05-13       Impact factor: 9.910

Review 8.  Autonomic dysfunction in peripheral nerve disease.

Authors:  Phillip A Low; Steven Vernino; Guillermo Suarez
Journal:  Muscle Nerve       Date:  2003-06       Impact factor: 3.217

9.  Anti-neuronal antibodies in acute pandysautonomia.

Authors:  Naoko Matsui; Takao Mitsui; Yasushi Ohshima; Kenji Yokoi; Makoto Kunishige; Fumikazu Yagi; Steven Vernino; Toshio Matsumoto; Ryuji Kaji
Journal:  Intern Med       Date:  2010-01-01       Impact factor: 1.271

10.  Pupillary supersensitivity and visual disturbance in Parkinson's disease.

Authors:  Norio Hori; Motoko Takamori; Masaaki Hirayama; Hirohisa Watanabe; Tomohiko Nakamura; Fumitada Yamashita; Hiroki Ito; Naoki Mabuchi; Gen Sobue
Journal:  Clin Auton Res       Date:  2008-02-11       Impact factor: 4.435

View more
  5 in total

Review 1.  Acquired neuropathies.

Authors:  Pierre Lozeron; Jean-Marc Trocello; Nathalie Kubis
Journal:  J Neurol       Date:  2013-06-16       Impact factor: 4.849

Review 2.  Autoimmune autonomic neuropathies and ganglionopathies: epidemiology, pathophysiology, and therapeutic advances.

Authors:  Elisabeth P Golden; Steven Vernino
Journal:  Clin Auton Res       Date:  2019-05-15       Impact factor: 4.435

3.  Autonomic involvement in subacute and chronic immune-mediated neuropathies.

Authors:  Anna Mazzeo; Claudia Stancanelli; Rita Di Leo; Giuseppe Vita
Journal:  Autoimmune Dis       Date:  2013-06-18

4.  Recurrent autonomic and sensory neuropathy in a patient with anti-ganglionic acetylcholine receptor antibodies.

Authors:  Eri Watanabe; Takako Fujita; Masayuki Shimono; Haruki Koike; Sawa Yasumoto; Shinichi Hirose
Journal:  eNeurologicalSci       Date:  2018-08-23

Review 5.  Guillain-Barré and Miller Fisher syndromes--new diagnostic classification.

Authors:  Benjamin R Wakerley; Antonino Uncini; Nobuhiro Yuki
Journal:  Nat Rev Neurol       Date:  2014-07-29       Impact factor: 42.937

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.